Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET)
This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer. This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Dat...
Saved in:
Published in | Breast (Edinburgh) Vol. 77; p. 103768 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.10.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer.
This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry.
The Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79–88) with median follow-up 41.9 months (IQR 27–60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029–1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086–1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152–0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094–0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226–0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321–4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532–5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05).
Early disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET.
•For PET patients, prognosis is largely determined by age and comorbidity, as most deaths are not breast cancer related.•Change of endocrine therapy and early disease response are not significantly associated with overall survival.•Patients with change of management to surgery do better; this may be due more to innate fitness for surgery than the operation. |
---|---|
AbstractList | Background: This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer. Methods: This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry. Results: The Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79–88) with median follow-up 41.9 months (IQR 27–60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029–1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086–1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152–0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094–0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226–0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321–4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532–5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05). Conclusion: Early disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET. This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer.BACKGROUNDThis study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer.This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry.METHODSThis was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry.The Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79-88) with median follow-up 41.9 months (IQR 27-60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029-1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086-1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152-0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094-0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226-0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321-4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532-5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05).RESULTSThe Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79-88) with median follow-up 41.9 months (IQR 27-60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029-1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086-1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152-0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094-0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226-0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321-4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532-5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05).Early disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET.CONCLUSIONEarly disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET. This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer. This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry. The Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79-88) with median follow-up 41.9 months (IQR 27-60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029-1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086-1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152-0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094-0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226-0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321-4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532-5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05). Early disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET. This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women (≥70) with breast cancer. This was an unplanned secondary analysis of a prospective, multicentre, observational study (The Age Gap study). Data were collected at baseline and regular intervals on patient, tumour and treatment characteristics with tumour RECIST response category recorded. Direct study follow-up was 24 months with longer-term survival data obtained from the UK cancer registry. The Age Gap study recruited 3316 women across 56 breast units. Primary endocrine therapy (PET) was initiated for 505/3316 (15 %) women; median age was 84 (IQR 79–88) with median follow-up 41.9 months (IQR 27–60). Death occurred in 205/505(40.6 %) patients, 160/205; 78 % non- Breast Cancer related, 45/205; 21.9 % Breast Cancer related. Multivariate analysis identified older age (HR-1.055(95 % Confidence Interval: 1.029–1.084); P < 0.001) and higher Charlson Index (HR-1.166 (1.086–1.252); P < 0.001) as risk factors for all-cause mortality, but conversion to surgery (HR-0.372(0.152–0.914); P = 0.031) was protective. Grade 3 cancer (G1 vs G3 HR-0.28 (0.094–0.829); P = 0.022 & G2 vs G3 HR-0.469 (0.226–0.973); P = 0.042), axillary positivity (axilla positivity HR-2.548 (1.321–4.816); P = 0.005) and change of endocrine therapy (HR-3.010 (1.532–5.913); P = 0.001) were associated with worse breast cancer specific survival (BCSS). RECIST category was not significantly associated with either overall survival or BCSS (P > 0.05). Early disease response and change of endocrine therapy are not significantly associated with overall survival, conversion to surgery is linked to improved outcome. Prognosis is largely determined by age and comorbidity in older women treated with PET. •For PET patients, prognosis is largely determined by age and comorbidity, as most deaths are not breast cancer related.•Change of endocrine therapy and early disease response are not significantly associated with overall survival.•Patients with change of management to surgery do better; this may be due more to innate fitness for surgery than the operation. • For PET patients, prognosis is largely determined by age and comorbidity, as most deaths are not breast cancer related. • Change of endocrine therapy and early disease response are not significantly associated with overall survival. • Patients with change of management to surgery do better; this may be due more to innate fitness for surgery than the operation. |
ArticleNumber | 103768 |
Author | Audisio, Riccardo Cheung, Kwok-Leung Reed, Malcolm Walters, Stephen Wyld, Lynda Hubbard, Thomas Morgan, Jenna Wright, Georgia Martin, Charlene |
Author_xml | – sequence: 1 givenname: Thomas orcidid: 0000-0003-4593-0853 surname: Hubbard fullname: Hubbard, Thomas organization: Royal Devon University Hospital NHS Trust, Exeter, UK – sequence: 2 givenname: Georgia surname: Wright fullname: Wright, Georgia organization: Royal Devon University Hospital NHS Trust, Exeter, UK – sequence: 3 givenname: Jenna surname: Morgan fullname: Morgan, Jenna organization: Division of Clinical Medicine, University of Sheffield, Sheffield, UK – sequence: 4 givenname: Charlene surname: Martin fullname: Martin, Charlene organization: Division of Clinical Medicine, University of Sheffield, Sheffield, UK – sequence: 5 givenname: Stephen surname: Walters fullname: Walters, Stephen organization: School for Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK – sequence: 6 givenname: Kwok-Leung surname: Cheung fullname: Cheung, Kwok-Leung organization: School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UK – sequence: 7 givenname: Riccardo surname: Audisio fullname: Audisio, Riccardo organization: University of Gothenberg, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden – sequence: 8 givenname: Malcolm surname: Reed fullname: Reed, Malcolm organization: Brighton and Sussex Medical School, Brighton, UK – sequence: 9 givenname: Lynda surname: Wyld fullname: Wyld, Lynda email: l.wyld@sheffield.ac.uk organization: Division of Clinical Medicine, University of Sheffield, Sheffield, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38996610$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UcFuGyEQRVWqxnH7B1XFMT3YBbPLwqVVFKVNpFTtIT0jFgYbaxdcwIn89yVdJ2ouPaFh3rw3894ZOgkxAELvKVlSQvmn7bJPoHNZrsiqqV-s4-IVmtGWrRaMCHKCZkRyspBdx0_RWc5bQohkXLxBp0xIyTklMzR-10GvYYRQsA4Wx30xcYSMXUw4DhYSfqh1wA--bDDoNBzwpIuNDqa2S60K2AmwS37U6YAh2GiSD4DLBpLeHfD5z6u7j2_Ra6eHDO-O7xz9-np1d3m9uP3x7eby4nZhGiLLAhyhrXWaMkNFV6-gjLZ9o6VlLas92bbGAW81GOF6w50zrhONk33FSqHZHN1MvDbqrToupaL26u9HTGulU_FmANV3QoDVbqVXfSOEFC2xnLueaCYsk7JyfZm4dvt-BGuqU0kPL0hfdoLfqHW8V5QyQplkleH8yJDi7z3kokafDQyDDhD3WTHSVdmW1ePmqJmgJsWcE7hnHUrUY-xqqyb71WPsaoq9jn34d8fnoaecK-DzBIDq-r2HpLLxUPOzPoEp1Rb_f4U_cKTEJg |
Cites_doi | 10.1093/geront/9.3_Part_1.179 10.1245/s10434-011-2070-z 10.1308/003588413X13629960045832 10.1002/bjs.10885 10.1136/bmj.297.6647.511 10.1016/j.surge.2013.11.021 10.1038/sj.bjc.6601742 10.1016/j.ejso.2014.02.224 10.1016/j.ejca.2008.10.026 10.7326/0003-4819-147-8-200710160-00010 10.1016/j.ejca.2020.10.015 10.1016/0022-3956(75)90026-6 10.1023/A:1006391902868 10.1002/pon.5054 10.1200/JCO.2006.08.8617 10.1093/annonc/mdg117 10.1016/S0140-6736(88)91478-X 10.1016/j.amjsurg.2015.11.005 10.1007/s10549-012-2114-5 10.3816/CBC.2007.n.038 10.1007/s10549-008-9930-7 10.1136/bmjopen-2016-015133 10.1016/0277-5379(88)90046-6 10.1016/0021-9681(87)90171-8 10.1093/bjs/znab005 10.1093/annonc/mdr630 10.1016/j.ejso.2015.05.022 10.4103/jdmimsu.jdmimsu_7_20 10.1016/S1470-2045(20)30741-5 10.1002/pon.4429 10.1007/s10549-017-4494-z 10.1016/S0960-9776(97)90557-9 10.1038/bjc.2011.105 10.1016/S0959-8049(02)00672-X 10.1002/bjs.4603 10.1093/bjs/znaa125 10.1093/bjs/znac435 |
ContentType | Journal Article |
Copyright | 2024 The Authors Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. 2024 The Authors 2024 |
Copyright_xml | – notice: 2024 The Authors – notice: Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2024 The Authors 2024 |
CorporateAuthor | the Bridging the Age Gap Trial Management Group Bridging the Age Gap Trial Management Group |
CorporateAuthor_xml | – name: the Bridging the Age Gap Trial Management Group – name: Bridging the Age Gap Trial Management Group |
DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/j.breast.2024.103768 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-3080 |
ExternalDocumentID | oai_doaj_org_article_b788edaf2a2b4889850d66fb0a38d399 10_1016_j_breast_2024_103768 38996610 S0960977624000997 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 123 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5VS 6I. 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAFTH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABJNI ABLJU ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD ADVLN AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HEC HMK HMO HVGLF HZ~ IHE J1W KOM L7B M29 M2X M41 MO0 N9A NCXOZ O-L O9- OAUVE OC~ OK1 OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPM RPZ SAE SCC SDF SDG SDP SEL SES SEW SSH SSZ T5K WUQ Z5R ~G- AFJKZ NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c409t-ef015dfa13c1870961315b4a9d353f01955cfe65aec8fbc6ffcf784f9b09698a3 |
IEDL.DBID | RPM |
ISSN | 0960-9776 1532-3080 |
IngestDate | Tue Oct 22 15:14:33 EDT 2024 Tue Sep 17 21:28:35 EDT 2024 Fri Oct 04 21:57:22 EDT 2024 Thu Sep 26 20:21:39 EDT 2024 Wed Oct 23 10:02:54 EDT 2024 Sat Sep 14 18:00:22 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Endocrine therapy Older adult Breast neoplasms |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c409t-ef015dfa13c1870961315b4a9d353f01955cfe65aec8fbc6ffcf784f9b09698a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Joint 1st author. |
ORCID | 0000-0003-4593-0853 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301393/ |
PMID | 38996610 |
PQID | 3079855335 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b788edaf2a2b4889850d66fb0a38d399 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11301393 proquest_miscellaneous_3079855335 crossref_primary_10_1016_j_breast_2024_103768 pubmed_primary_38996610 elsevier_sciencedirect_doi_10_1016_j_breast_2024_103768 |
PublicationCentury | 2000 |
PublicationDate | 2024-10-01 |
PublicationDateYYYYMMDD | 2024-10-01 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Breast (Edinburgh) |
PublicationTitleAlternate | Breast |
PublicationYear | 2024 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Chan, Chong, Chia, Cheung (bib5) 2023; 110 (bib6) 2018 Fayers, Aaronson, Bjordal, Groenvold, Curran, Bottomley (bib28) 2001 Charlson, Pompei, Ales, MacKenzie (bib24) 1987; 40 Burton, Kilner, Wyld, Lifford, Gordon, Allison (bib34) 2017; 26 Robertson, Howell, Buzdar, Von Euler, Lee (bib42) 1999; 58 Wink, Woensdregt, Nieuwenhuijzen, van der Sangen, Hutschemaekers, Roukema (bib9) 2012; 19 Morgan, Collins, Robinson, Cheung, Audisio, Reed (bib21) 2015; 41 Wylie, Ravichandran (bib11) 2013; 95 (bib12) 2022 Wyld, Reed, Morgan, Collins, Ward, Holmes (bib43) 2021; 142 Fennessy, Bates, MacRae, Riley, Houghton, Baum (bib20) 2004; 91 Syed, Al-Khyatt, Johnston, Wong, Winterbottom, Kennedy (bib44) 2011; 104 Wyld, Reed, Collins, Burton, Lifford, Edwards (bib32) 2021; 108 Eisenhauer, Therasse, Bogaerts, Schwartz, Sargent, Ford (bib30) 2009; 45 Mahoney, Barthel (bib26) 1965; 14 Coates, Keshaviah, Thurlimann, Mouridsen, Mauriac, Forbes (bib36) 2007; 25 Robertson, Todd, Ellis, Elston, Blamey (bib14) 1988; 297 Biganzoli, Battisti, Wildiers, McCartney, Colloca, Kunkler (bib7) 2021; 22 Wyld, Collins (bib23) 2012 Shrestha, Martin, Burton, Walters, Collins, Wyld (bib33) 2019; 28 Mustacchi, Ceccherini, Milani, Pluchinotta, De Matteis, Maiorino (bib17) 2003; 14 Wyld, Garg, Kumar, Brown, Reed (bib10) 2004; 90 Johnston, Kenny, Syed, Robertson, Pinder, Winterbottom (bib13) 2012; 23 Presant, Bosserman, Young, Vakil, Horns, Upadhyaya (bib37) 2007; 7 Fentiman, Van Zijl, Karydas, Chaudary, Margreiter, Legrand (bib19) 2003; 39 Von Elm, Altman, Egger, Pocock, Gøtzsche, Vandenbroucke (bib31) 2007; 147 Kantor, Pesce, Liederbach, Wang, Winchester, Yao (bib8) 2016; 211 Gazet, Ford, Bland, Coombes, Dixon (bib18) 1988; 331 Howell, Mackintosh, Jones, Redford, Wagstaff, Sellwood (bib41) 1988; 24 Morgan, Shrestha, Reed, Herbert, Bradburn, Walters (bib22) 2021; 108 Mathew, Agrawal, Asgeirsson, Buhari, Jackson, Cheung (bib40) 2009; 113 Capasso, Nuzzo, Labonia, Landi, Rossi, De Matteis (bib16) 2000; 50 Willsher, Robertson, Jackson, Al-Hilaly, Blarney (bib15) 1997; 6 Morgan, Reed, Wyld (bib2) 2014; 40 Thomas, Rowell, Crichton, Cain (bib38) 2018; 167 Layfield, Mohamud, Odofin, Walsh, Royle, Cutress (bib39) 2015; 13 Rai, Vagha, Shukla, Bhake (bib29) 2020; 15 Folstein, Folstein, McHugh (bib25) 1975; 12 Murphy, Bartholomew, Carpentier, Bluethmann, Vernon (bib35) 2012; 134 Morgan, Wyld, Collins, Reed (bib1) 2014; 5 Collins, Reed, Lifford, Burton, Edwards, Ring (bib3) 2017; 7 Lawton, Brody (bib27) 1969; 9 Ward, Richards, Morgan, Holmes, Broggio, Collins (bib4) 2018; 105 Wink (10.1016/j.breast.2024.103768_bib9) 2012; 19 Morgan (10.1016/j.breast.2024.103768_bib22) 2021; 108 Wyld (10.1016/j.breast.2024.103768_bib32) 2021; 108 Wyld (10.1016/j.breast.2024.103768_bib10) 2004; 90 Burton (10.1016/j.breast.2024.103768_bib34) 2017; 26 Gazet (10.1016/j.breast.2024.103768_bib18) 1988; 331 Fentiman (10.1016/j.breast.2024.103768_bib19) 2003; 39 Lawton (10.1016/j.breast.2024.103768_bib27) 1969; 9 Fayers (10.1016/j.breast.2024.103768_bib28) 2001 Eisenhauer (10.1016/j.breast.2024.103768_bib30) 2009; 45 Chan (10.1016/j.breast.2024.103768_bib5) 2023; 110 Layfield (10.1016/j.breast.2024.103768_bib39) 2015; 13 Mathew (10.1016/j.breast.2024.103768_bib40) 2009; 113 Mustacchi (10.1016/j.breast.2024.103768_bib17) 2003; 14 Shrestha (10.1016/j.breast.2024.103768_bib33) 2019; 28 Collins (10.1016/j.breast.2024.103768_bib3) 2017; 7 (10.1016/j.breast.2024.103768_bib6) 2018 Robertson (10.1016/j.breast.2024.103768_bib42) 1999; 58 Folstein (10.1016/j.breast.2024.103768_bib25) 1975; 12 Presant (10.1016/j.breast.2024.103768_bib37) 2007; 7 Morgan (10.1016/j.breast.2024.103768_bib2) 2014; 40 Ward (10.1016/j.breast.2024.103768_bib4) 2018; 105 Murphy (10.1016/j.breast.2024.103768_bib35) 2012; 134 Syed (10.1016/j.breast.2024.103768_bib44) 2011; 104 Thomas (10.1016/j.breast.2024.103768_bib38) 2018; 167 Charlson (10.1016/j.breast.2024.103768_bib24) 1987; 40 Coates (10.1016/j.breast.2024.103768_bib36) 2007; 25 Wyld (10.1016/j.breast.2024.103768_bib43) 2021; 142 Willsher (10.1016/j.breast.2024.103768_bib15) 1997; 6 Kantor (10.1016/j.breast.2024.103768_bib8) 2016; 211 Wylie (10.1016/j.breast.2024.103768_bib11) 2013; 95 Howell (10.1016/j.breast.2024.103768_bib41) 1988; 24 Morgan (10.1016/j.breast.2024.103768_bib1) 2014; 5 Biganzoli (10.1016/j.breast.2024.103768_bib7) 2021; 22 Morgan (10.1016/j.breast.2024.103768_bib21) 2015; 41 Wyld (10.1016/j.breast.2024.103768_bib23) 2012 Mahoney (10.1016/j.breast.2024.103768_bib26) 1965; 14 (10.1016/j.breast.2024.103768_bib12) 2022 Rai (10.1016/j.breast.2024.103768_bib29) 2020; 15 Von Elm (10.1016/j.breast.2024.103768_bib31) 2007; 147 Capasso (10.1016/j.breast.2024.103768_bib16) 2000; 50 Fennessy (10.1016/j.breast.2024.103768_bib20) 2004; 91 Johnston (10.1016/j.breast.2024.103768_bib13) 2012; 23 Robertson (10.1016/j.breast.2024.103768_bib14) 1988; 297 |
References_xml | – volume: 13 start-page: 61 year: 2015 end-page: 68 ident: bib39 article-title: Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma publication-title: Surgeon contributor: fullname: Cutress – volume: 297 start-page: 511 year: 1988 end-page: 514 ident: bib14 article-title: Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer publication-title: Br Med J contributor: fullname: Blamey – volume: 24 start-page: 1567 year: 1988 end-page: 1572 ident: bib41 article-title: The definition of the ‘no change’category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast publication-title: Eur J Cancer Clin Oncol contributor: fullname: Sellwood – volume: 41 start-page: 1234 year: 2015 end-page: 1242 ident: bib21 article-title: Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer publication-title: Eur J Surg Oncol contributor: fullname: Reed – year: 2001 ident: bib28 article-title: The EORTC QLQ-C30 scoring manual contributor: fullname: Bottomley – volume: 40 start-page: 676 year: 2014 end-page: 684 ident: bib2 article-title: Primary endocrine therapy as a treatment for older women with operable breast cancer–a comparison of randomised controlled trial and cohort study findings publication-title: Eur J Surg Oncol contributor: fullname: Wyld – volume: 19 start-page: 1185 year: 2012 end-page: 1191 ident: bib9 article-title: Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer publication-title: Ann Surg Oncol contributor: fullname: Roukema – volume: 26 start-page: 2094 year: 2017 end-page: 2100 ident: bib34 article-title: Information needs and decision‐making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer publication-title: Psycho Oncol contributor: fullname: Allison – volume: 15 start-page: 202 year: 2020 end-page: 208 ident: bib29 article-title: Comparison of various scoring systems by immunohistochemistry for evaluating hormone receptors (Estrogen receptor and progesterone receptor) in carcinoma of breast publication-title: Journal of Datta Meghe Institute of Medical Sciences University contributor: fullname: Bhake – volume: 108 start-page: 315 year: 2021 end-page: 325 ident: bib22 article-title: Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes publication-title: Br J Surg contributor: fullname: Walters – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: bib25 article-title: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res contributor: fullname: McHugh – volume: 7 start-page: 775 year: 2007 end-page: 778 ident: bib37 article-title: Aromatase inhibitor–associated arthralgia and/or bone pain: frequency and characterization in non–clinical trial patients publication-title: Clin Breast Cancer contributor: fullname: Upadhyaya – volume: 6 start-page: 150 year: 1997 end-page: 154 ident: bib15 article-title: Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer publication-title: Breast contributor: fullname: Blarney – volume: 113 start-page: 403 year: 2009 end-page: 407 ident: bib40 article-title: Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience publication-title: Breast Cancer Res Treat contributor: fullname: Cheung – volume: 211 start-page: 541 year: 2016 end-page: 545 ident: bib8 article-title: Surgery and hormone therapy trends in octogenarians with invasive breast cancer publication-title: Am J Surg contributor: fullname: Yao – year: 2018 ident: bib6 article-title: Early and locally advanced breast cancer: diagnosis and management [NG101] – volume: 23 start-page: 2296 year: 2012 end-page: 2300 ident: bib13 article-title: A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up publication-title: Ann Oncol contributor: fullname: Winterbottom – volume: 90 start-page: 1486 year: 2004 end-page: 1491 ident: bib10 article-title: Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines publication-title: Br J Cancer contributor: fullname: Reed – volume: 147 start-page: 573 year: 2007 end-page: 577 ident: bib31 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Ann Intern Med contributor: fullname: Vandenbroucke – volume: 104 start-page: 1393 year: 2011 end-page: 1400 ident: bib44 article-title: Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre publication-title: Br J Cancer contributor: fullname: Kennedy – volume: 110 start-page: 420 year: 2023 end-page: 431 ident: bib5 article-title: Revisiting primary endocrine therapy versus surgery in older women with breast cancer: meta-analysis publication-title: Br J Surg contributor: fullname: Cheung – volume: 5 year: 2014 ident: bib1 article-title: Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) publication-title: Cochrane Database Syst Rev contributor: fullname: Reed – volume: 28 start-page: 1367 year: 2019 end-page: 1380 ident: bib33 article-title: Quality of life versus length of life considerations in cancer patients: a systematic literature review publication-title: Psycho Oncol contributor: fullname: Wyld – volume: 45 start-page: 228 year: 2009 end-page: 247 ident: bib30 article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) publication-title: Eur J Cancer contributor: fullname: Ford – volume: 108 start-page: 499 year: 2021 end-page: 510 ident: bib32 article-title: Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices publication-title: Br J Surg contributor: fullname: Edwards – volume: 14 start-page: 414 year: 2003 end-page: 420 ident: bib17 article-title: Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial publication-title: Ann Oncol contributor: fullname: Maiorino – volume: 331 start-page: 679 year: 1988 end-page: 681 ident: bib18 article-title: Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer publication-title: Lancet contributor: fullname: Dixon – volume: 58 start-page: 157 year: 1999 end-page: 162 ident: bib42 article-title: Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer publication-title: Breast Cancer Res Treat contributor: fullname: Lee – volume: 134 start-page: 459 year: 2012 end-page: 478 ident: bib35 article-title: Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review publication-title: Breast Cancer Res Treat contributor: fullname: Vernon – volume: 14 start-page: 61 year: 1965 end-page: 65 ident: bib26 article-title: Functional evaluation: the barthel index publication-title: Md State Med J contributor: fullname: Barthel – volume: 9 start-page: 179 year: 1969 end-page: 186 ident: bib27 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontol contributor: fullname: Brody – volume: 39 start-page: 300 year: 2003 end-page: 308 ident: bib19 article-title: Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen publication-title: Eur J Cancer contributor: fullname: Legrand – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: bib24 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chron Dis contributor: fullname: MacKenzie – volume: 91 start-page: 699 year: 2004 end-page: 704 ident: bib20 article-title: Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer publication-title: J Br Surg contributor: fullname: Baum – year: 2022 ident: bib12 publication-title: NABCOP 2022 annual report – volume: 7 year: 2017 ident: bib3 article-title: Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial publication-title: BMJ Open contributor: fullname: Ring – year: 2012 ident: bib23 article-title: Bridging the age gap in breast Cancer: improving outcomes for older women NIHR Programme grant 2012-17RP-PG-1209-10071 contributor: fullname: Collins – volume: 167 start-page: 73 year: 2018 end-page: 80 ident: bib38 article-title: An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly publication-title: Breast Cancer Res Treat contributor: fullname: Cain – volume: 105 start-page: 1454 year: 2018 end-page: 1463 ident: bib4 article-title: Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival publication-title: J Br Surg contributor: fullname: Collins – volume: 50 start-page: 20 year: 2000 ident: bib16 article-title: Surgery plus tamoxifen versus tamoxifen as treatment of stage I and II breast cancer in over to 70 years old women: ten years follow-up publication-title: Ann Oncol: KLUWER ACADEMIC PUBL SPUIBOULEVARD contributor: fullname: De Matteis – volume: 142 start-page: 48 year: 2021 end-page: 62 ident: bib43 article-title: Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life publication-title: Eur J Cancer contributor: fullname: Holmes – volume: 22 start-page: e327 year: 2021 end-page: e340 ident: bib7 article-title: Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG) publication-title: Lancet Oncol contributor: fullname: Kunkler – volume: 95 start-page: 353 year: 2013 end-page: 356 ident: bib11 article-title: A UK national survey of breast surgeons on primary endocrine therapy of early operable breast cancer publication-title: Ann R Coll Surg Engl contributor: fullname: Ravichandran – volume: 25 start-page: 486 year: 2007 end-page: 492 ident: bib36 article-title: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 publication-title: J Clin Oncol contributor: fullname: Forbes – year: 2022 ident: 10.1016/j.breast.2024.103768_bib12 – volume: 9 start-page: 179 year: 1969 ident: 10.1016/j.breast.2024.103768_bib27 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontol doi: 10.1093/geront/9.3_Part_1.179 contributor: fullname: Lawton – volume: 19 start-page: 1185 year: 2012 ident: 10.1016/j.breast.2024.103768_bib9 article-title: Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-011-2070-z contributor: fullname: Wink – volume: 95 start-page: 353 year: 2013 ident: 10.1016/j.breast.2024.103768_bib11 article-title: A UK national survey of breast surgeons on primary endocrine therapy of early operable breast cancer publication-title: Ann R Coll Surg Engl doi: 10.1308/003588413X13629960045832 contributor: fullname: Wylie – volume: 105 start-page: 1454 year: 2018 ident: 10.1016/j.breast.2024.103768_bib4 article-title: Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival publication-title: J Br Surg doi: 10.1002/bjs.10885 contributor: fullname: Ward – volume: 297 start-page: 511 year: 1988 ident: 10.1016/j.breast.2024.103768_bib14 article-title: Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer publication-title: Br Med J doi: 10.1136/bmj.297.6647.511 contributor: fullname: Robertson – volume: 13 start-page: 61 year: 2015 ident: 10.1016/j.breast.2024.103768_bib39 article-title: Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma publication-title: Surgeon doi: 10.1016/j.surge.2013.11.021 contributor: fullname: Layfield – volume: 90 start-page: 1486 year: 2004 ident: 10.1016/j.breast.2024.103768_bib10 article-title: Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601742 contributor: fullname: Wyld – volume: 5 year: 2014 ident: 10.1016/j.breast.2024.103768_bib1 article-title: Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) publication-title: Cochrane Database Syst Rev contributor: fullname: Morgan – volume: 40 start-page: 676 year: 2014 ident: 10.1016/j.breast.2024.103768_bib2 article-title: Primary endocrine therapy as a treatment for older women with operable breast cancer–a comparison of randomised controlled trial and cohort study findings publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2014.02.224 contributor: fullname: Morgan – volume: 45 start-page: 228 year: 2009 ident: 10.1016/j.breast.2024.103768_bib30 article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) publication-title: Eur J Cancer doi: 10.1016/j.ejca.2008.10.026 contributor: fullname: Eisenhauer – volume: 147 start-page: 573 year: 2007 ident: 10.1016/j.breast.2024.103768_bib31 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Ann Intern Med doi: 10.7326/0003-4819-147-8-200710160-00010 contributor: fullname: Von Elm – volume: 142 start-page: 48 year: 2021 ident: 10.1016/j.breast.2024.103768_bib43 article-title: Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life publication-title: Eur J Cancer doi: 10.1016/j.ejca.2020.10.015 contributor: fullname: Wyld – volume: 12 start-page: 189 year: 1975 ident: 10.1016/j.breast.2024.103768_bib25 article-title: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 contributor: fullname: Folstein – volume: 58 start-page: 157 year: 1999 ident: 10.1016/j.breast.2024.103768_bib42 article-title: Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006391902868 contributor: fullname: Robertson – year: 2001 ident: 10.1016/j.breast.2024.103768_bib28 contributor: fullname: Fayers – volume: 28 start-page: 1367 year: 2019 ident: 10.1016/j.breast.2024.103768_bib33 article-title: Quality of life versus length of life considerations in cancer patients: a systematic literature review publication-title: Psycho Oncol doi: 10.1002/pon.5054 contributor: fullname: Shrestha – volume: 25 start-page: 486 year: 2007 ident: 10.1016/j.breast.2024.103768_bib36 article-title: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.8617 contributor: fullname: Coates – year: 2018 ident: 10.1016/j.breast.2024.103768_bib6 – volume: 14 start-page: 414 year: 2003 ident: 10.1016/j.breast.2024.103768_bib17 article-title: Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial publication-title: Ann Oncol doi: 10.1093/annonc/mdg117 contributor: fullname: Mustacchi – volume: 331 start-page: 679 year: 1988 ident: 10.1016/j.breast.2024.103768_bib18 article-title: Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer publication-title: Lancet doi: 10.1016/S0140-6736(88)91478-X contributor: fullname: Gazet – volume: 211 start-page: 541 year: 2016 ident: 10.1016/j.breast.2024.103768_bib8 article-title: Surgery and hormone therapy trends in octogenarians with invasive breast cancer publication-title: Am J Surg doi: 10.1016/j.amjsurg.2015.11.005 contributor: fullname: Kantor – volume: 134 start-page: 459 year: 2012 ident: 10.1016/j.breast.2024.103768_bib35 article-title: Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2114-5 contributor: fullname: Murphy – volume: 7 start-page: 775 year: 2007 ident: 10.1016/j.breast.2024.103768_bib37 article-title: Aromatase inhibitor–associated arthralgia and/or bone pain: frequency and characterization in non–clinical trial patients publication-title: Clin Breast Cancer doi: 10.3816/CBC.2007.n.038 contributor: fullname: Presant – volume: 113 start-page: 403 year: 2009 ident: 10.1016/j.breast.2024.103768_bib40 article-title: Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-008-9930-7 contributor: fullname: Mathew – volume: 7 year: 2017 ident: 10.1016/j.breast.2024.103768_bib3 article-title: Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial publication-title: BMJ Open doi: 10.1136/bmjopen-2016-015133 contributor: fullname: Collins – volume: 24 start-page: 1567 year: 1988 ident: 10.1016/j.breast.2024.103768_bib41 article-title: The definition of the ‘no change’category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast publication-title: Eur J Cancer Clin Oncol doi: 10.1016/0277-5379(88)90046-6 contributor: fullname: Howell – volume: 40 start-page: 373 year: 1987 ident: 10.1016/j.breast.2024.103768_bib24 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chron Dis doi: 10.1016/0021-9681(87)90171-8 contributor: fullname: Charlson – volume: 108 start-page: 499 year: 2021 ident: 10.1016/j.breast.2024.103768_bib32 article-title: Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices publication-title: Br J Surg doi: 10.1093/bjs/znab005 contributor: fullname: Wyld – volume: 23 start-page: 2296 year: 2012 ident: 10.1016/j.breast.2024.103768_bib13 article-title: A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdr630 contributor: fullname: Johnston – volume: 41 start-page: 1234 year: 2015 ident: 10.1016/j.breast.2024.103768_bib21 article-title: Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2015.05.022 contributor: fullname: Morgan – volume: 15 start-page: 202 year: 2020 ident: 10.1016/j.breast.2024.103768_bib29 article-title: Comparison of various scoring systems by immunohistochemistry for evaluating hormone receptors (Estrogen receptor and progesterone receptor) in carcinoma of breast publication-title: Journal of Datta Meghe Institute of Medical Sciences University doi: 10.4103/jdmimsu.jdmimsu_7_20 contributor: fullname: Rai – volume: 22 start-page: e327 year: 2021 ident: 10.1016/j.breast.2024.103768_bib7 article-title: Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG) publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30741-5 contributor: fullname: Biganzoli – volume: 50 start-page: 20 year: 2000 ident: 10.1016/j.breast.2024.103768_bib16 article-title: Surgery plus tamoxifen versus tamoxifen as treatment of stage I and II breast cancer in over to 70 years old women: ten years follow-up publication-title: Ann Oncol: KLUWER ACADEMIC PUBL SPUIBOULEVARD contributor: fullname: Capasso – volume: 26 start-page: 2094 year: 2017 ident: 10.1016/j.breast.2024.103768_bib34 article-title: Information needs and decision‐making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer publication-title: Psycho Oncol doi: 10.1002/pon.4429 contributor: fullname: Burton – volume: 14 start-page: 61 year: 1965 ident: 10.1016/j.breast.2024.103768_bib26 article-title: Functional evaluation: the barthel index publication-title: Md State Med J contributor: fullname: Mahoney – volume: 167 start-page: 73 year: 2018 ident: 10.1016/j.breast.2024.103768_bib38 article-title: An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4494-z contributor: fullname: Thomas – volume: 6 start-page: 150 year: 1997 ident: 10.1016/j.breast.2024.103768_bib15 article-title: Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer publication-title: Breast doi: 10.1016/S0960-9776(97)90557-9 contributor: fullname: Willsher – volume: 104 start-page: 1393 year: 2011 ident: 10.1016/j.breast.2024.103768_bib44 article-title: Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre publication-title: Br J Cancer doi: 10.1038/bjc.2011.105 contributor: fullname: Syed – volume: 39 start-page: 300 year: 2003 ident: 10.1016/j.breast.2024.103768_bib19 article-title: Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen publication-title: Eur J Cancer doi: 10.1016/S0959-8049(02)00672-X contributor: fullname: Fentiman – volume: 91 start-page: 699 year: 2004 ident: 10.1016/j.breast.2024.103768_bib20 article-title: Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer publication-title: J Br Surg doi: 10.1002/bjs.4603 contributor: fullname: Fennessy – volume: 108 start-page: 315 year: 2021 ident: 10.1016/j.breast.2024.103768_bib22 article-title: Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes publication-title: Br J Surg doi: 10.1093/bjs/znaa125 contributor: fullname: Morgan – volume: 110 start-page: 420 year: 2023 ident: 10.1016/j.breast.2024.103768_bib5 article-title: Revisiting primary endocrine therapy versus surgery in older women with breast cancer: meta-analysis publication-title: Br J Surg doi: 10.1093/bjs/znac435 contributor: fullname: Chan – year: 2012 ident: 10.1016/j.breast.2024.103768_bib23 contributor: fullname: Wyld |
SSID | ssj0009368 |
Score | 2.4403028 |
Snippet | This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of older women... • For PET patients, prognosis is largely determined by age and comorbidity, as most deaths are not breast cancer related. • Change of endocrine therapy and... Background: This study reports the detailed management and outcomes of women treated with Primary Endocrine Therapy (PET) in a large prospective UK cohort of... |
SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 103768 |
SubjectTerms | Breast neoplasms Endocrine therapy Older adult Original |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T-QwELYQBaJBHM_cATISBRQRm_Vj4xIQaIW0iAIkOstPARLJCXaL-_c3YyewCwUNbeLEjxl7PifffCbkyGFqD4Sd0jj8dCOVLM0oiFJxzlWlog0Sk5MnN3J8z68fxMPcUV_ICcvywHngTi3s0YI3cWiGFpxN1WLgpYx2YFjtIbqm1bcS_Waql9tlsu4T5RKbyyLFG7mTQ57yzFFadS4QJb3-hXj0FW9-pk3OxaGrdbLWAUh6lhv-iyyFZoOsTLpf5Jvk5YPQQk3jaTubglOFNwrolLZ4JjdNqgsUv8DSgPrGNDebOvSAV5q458HnAn-zGgUNjW8dZgrSnLH1jx7fXt6dbJH7q8u7i3HZnalQOtjJTcsQIf77aCrmKpiqCqJ5JSw3yjPBImYPCheDFCa4OlonY3RxVPOoLJRVtWHbZLlpm7BLKKx1Fp6yYcQM97DT8I5zZoWHopEbXpCyH2DdNVb3nLJnnXum0SA6G6Qg52iF97IofJ0ugDvozh30d-5QkFFvQ91hiIwN4FVP31R_2JtcwxTD_yamCe3sTcMyCPUALhYF2cku8N5IlCcEiDMoSL3gHAu9WLzTPD0mGe8K4APgb_b7J_r9h6xiXzLNcI8sT19nYR_g0tQepJnxH22YFeQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Elsevier ScienceDirect Freedom Collection dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrYS4IN6kQGUkDnCIdrOx8ziWqtUW1AqJVurN8pMuEkm13T303zNjO20Dh0o9Jpkk48x45nMy8wXgk6HWHkw7uTL06qZqq1zVTuQt57wtWq9dRc3JxyfV4ox_OxfnW7A_9MJQWWWK_TGmh2id9kzT05xeLpfTn4EsrcbJzAPOqR_BNqYjziewvXf0fXFyy71bho44ks_phKGDLpR5aar9pqLKOQ8N6MS5eidDBSL_UaL6H4j-W095J0EdPoOnCVmyvaj8c9hy3Qt4fJy-nb-EP7eVLkx1lvWbNQ7aXTGEraynn3WzQMfA6NUsc0R8zKLazJBrrFgoSnc2ClxGmgrmOtsbaiFksZXrmn3-cXD65RWcHR6c7i_y9LOF3OASb507j8DAelWUpsA53GKaL4TmqrWlKD21FQrjXSWUM43XpvLe-LrhvtUo2zaqfA2Tru_cW2AYBDWepV1dKm5xCWIN56UWFkU9VzyDfHjAMikrh2Kz3zKOTJJBZDRIBl_JCjeyxIgddvSrXzK5hNS4lndW-bmaawxKbSNmtqq8nqmysYjCMqgHG8qRg-Gllvfc_uNgcolzjz6oqM71myuJ8RHvg4BZZPAmusCNksRbiNhnlkEzco7RKMZHuuVF4PcuEFcgMC93HqzyO3hCW7Ho8D1M1quN-4Dgaa130-T4C8cxGf0 priority: 102 providerName: Elsevier |
Title | Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET) |
URI | https://dx.doi.org/10.1016/j.breast.2024.103768 https://www.ncbi.nlm.nih.gov/pubmed/38996610 https://www.proquest.com/docview/3079855335/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC11301393 https://doaj.org/article/b788edaf2a2b4889850d66fb0a38d399 |
Volume | 77 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFH9ah4S4IL4JH5WROMAhbVM7TnIc06ZC1WlCm9jN8ucoosnUtQcu_O082_FY4YDEKVLiJHbes9_P9u_3AvBWe2kPhp1car90wxuey8qWecMYa4rGKcu9OHlxwmfn7NNFebEHPGlhAmlfq-Wo_b4atcuvgVt5tdLjxBMbny4OCxx4EbnQ8QAGFaVpjp5S7dIggPPYPEd0w5NgLrC6lKd6ew7llAW9uU-xeisghbz9O3Hpb9z5J33yVjw6fgD3eyBJDmKFH8KebR_B3UW_Vf4YVr-JLUS2hnTbDTqXvSaIUknn_81NQvYF4ldiifV5jkmsNtHeE9YkcNCtiQWuYlYKYlvTaa8YJFG59YO8Oz06e_8Ezo-Pzg5nef9vhVzjjG6TW4c4wDhZUF1gl20wqhelYrIxtKTOqwhL7SwvpdW1U5o7p11VM9coLNvUkj6F_bZr7XMgOOYpvEvZikpmcMZhNGNUlQaLOiZZBnn6wKKvrEjcsm8itkx4g4hokAw-eCvclPUJsMOJbn0pejcQCqfu1kg3lVOFY1BTlxPDuVMTSWuDoCuDKtlQ9FgiYgR81PIfr3-TTC6wq_n9E9nabnstcDjE9yA-LjN4Fl3gppI-TSFCnUkG9Y5z7LRi9wp6d0jnnbz5xf_f-hLu-RZEkuEr2N-st_Y1gqWNGsJg9LMYwp2Dj_PZiT_OP3-ZD8PSwzD0m1_OxBu_ |
link.rule.ids | 230,315,733,786,790,870,891,2115,4521,24144,27955,27956,45618,45712,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXxJvwNBIHOITdbOwkPkLVaoFuhcRW6s3ysywSSbXdPXDhtzNjJ20DBySuySQZZ8Yzn51vJgCvLZX2YNrJtaWtm0pWua69yCXnXBYyGF9RcfLiqJof808n4mQH9oZaGKJV9rE_xfQYrfsjk_5tTs5Wq8nX2CytxsnMI86pr8F1QgPE63r365LnIctYD0fSOYkP9XOR5GWI-U2UyhmP5efUcfVKfopt_Edp6m8Y-ieb8kp6OrgDt3tcyd4n1e_Cjm_vwY1F_-X8Pvy45Lkw3TrWbTc4ZH_OELSyjn7VzWIzBkYbs8xT22OW1GaWHGPNIiXduyRwlppUMN-6zlIBIUuFXD_Zmy_7y7cP4Phgf7k3z_tfLeQWF3ib3AeEBS7oorQFzmCJSb4QhmvpSlEGKioUNvhKaG-bYGwVgg11w4M0KCsbXT6E3bZr_WNgGAINXmV8XWrucAHiLOelEQ5FA9c8g3x4wapXVg1Us-8qjUyRQVQySAYfyAoXstQPOx7o1qeqdwhlcCXvnQ4zPTMYkmQjpq6qgpnqsnGIwTKoBxuqkXvhrVb_ePyrweQKZx59TtGt77bnCqMjPgfhssjgUXKBCyWpayEin2kGzcg5RqMYn2lX32J37wJRBcLy8sl_q_wSbs6Xi0N1-PHo81O4RWcS_fAZ7G7WW_8cYdTGvIjT5DfxoBvQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3pSUl5E4wCG7m42dxxFKV-Wx1R5aqRIHy09Y6Car3ewBfj0zdly65YDUazJOMvZ4_Dn55gshrzWW9sCyk0qNr26KukhlaXlaM8bqrHbKFlicPD0ujk7ZpzN-1rMq1z2tstFqPmjOF4Nm_t1zK5cLPYw8seFsepBB4gXkkg-Xxg1vklswacdl3KlHwd3cl8EhQk8B4xSxbM5zuxQSvpFJOWa-6hyFVi8tS169f2t1-hd9XiVRXlqVJnfJ1-hPIKP8HGw6NdC_r0g9Xs_he-ROD1bpu2Bzn9ywzQOyO-0_xz8ki7_kGSobQ9tNBwFs1xSQMG3x_9_UKzxQfNtLLWop09ApVGO0rajnuVsTDJZB-YLaxrQaqxJpqA77Rd_MDk_ePiKnk8OTg6O0_39DqmHX2KXWAdYwTma5ziAt1IAcMq6YrE3Oc4eVilw7W3BpdeWULpzTrqyYqxXY1pXMH5Odpm3sE0IhrypopWyZS2ZgV2M0Y7niBkwdkywhaRw-0T-siPy1HyJ4JnC4RRjuhLzHMb6wRZFtf6BdfRN9zwtVVpU10o3lWEGeqys-MkXh1EjmlQFgl5AyRojo8UrAIXCp-X9u_yoGlIDpjN9oZGPbzVpAyoX7AAbnCdkLAXbxkCiFCHBqlJBqK_S2vNg-AwHlJcNjAO1fv-lLsjv7MBFfPh5_fkpuozOB0_iM7HSrjX0O2KxTL_wk_ANcNDs3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+and+outcomes+for+older+women+with+early+breast+cancer+treated+with+primary+endocrine+therapy+%28PET%29&rft.jtitle=Breast+%28Edinburgh%29&rft.au=Hubbard%2C+Thomas&rft.au=Wright%2C+Georgia&rft.au=Morgan%2C+Jenna&rft.au=Martin%2C+Charlene&rft.date=2024-10-01&rft.pub=Elsevier+Ltd&rft.issn=0960-9776&rft.volume=77&rft_id=info:doi/10.1016%2Fj.breast.2024.103768&rft.externalDocID=S0960977624000997 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-9776&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-9776&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-9776&client=summon |